Danuta J. Herzyk

1.9k total citations
47 papers, 1.3k citations indexed

About

Danuta J. Herzyk is a scholar working on Immunology, Molecular Biology and Small Animals. According to data from OpenAlex, Danuta J. Herzyk has authored 47 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Immunology, 10 papers in Molecular Biology and 7 papers in Small Animals. Recurrent topics in Danuta J. Herzyk's work include Immune Response and Inflammation (9 papers), Immunotoxicology and immune responses (8 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Danuta J. Herzyk is often cited by papers focused on Immune Response and Inflammation (9 papers), Immunotoxicology and immune responses (8 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Danuta J. Herzyk collaborates with scholars based in United States, United Kingdom and Switzerland. Danuta J. Herzyk's co-authors include Mark D. Wewers, James N. Allen, Peter J. Bugelski, Timothy K. Hart, Elizabeth R. Gore, Jayanthi Wolf, Frederique M. Poulet, Joseph J. DeGeorge, Curtis C. Maier and W. Bruce Davis and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Immunology and Journal of Applied Physiology.

In The Last Decade

Danuta J. Herzyk

47 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Danuta J. Herzyk United States 20 682 343 235 230 189 47 1.3k
Ullrich Schwertschlag United States 18 811 1.2× 323 0.9× 211 0.9× 67 0.3× 315 1.7× 50 1.9k
S Douches United States 9 437 0.6× 254 0.7× 156 0.7× 346 1.5× 257 1.4× 11 1.1k
J.L. Touraine France 20 938 1.4× 321 0.9× 88 0.4× 102 0.4× 190 1.0× 106 1.8k
Takeshi Otsuka Japan 25 1.0k 1.5× 458 1.3× 192 0.8× 86 0.4× 425 2.2× 60 2.1k
Zaher A. Radi United States 16 416 0.6× 238 0.7× 106 0.5× 58 0.3× 338 1.8× 64 1.4k
Sharad D. Deodhar United States 23 375 0.5× 317 0.9× 214 0.9× 156 0.7× 333 1.8× 85 1.6k
Jürgen E. Scherberich Germany 22 422 0.6× 427 1.2× 356 1.5× 68 0.3× 203 1.1× 85 1.9k
Eric R. Hurd United States 26 788 1.2× 345 1.0× 148 0.6× 376 1.6× 218 1.2× 57 2.4k
Jeng‐Hsien Yen Taiwan 29 1.3k 2.0× 556 1.6× 108 0.5× 139 0.6× 368 1.9× 132 2.7k
R. van Furth Netherlands 17 505 0.7× 366 1.1× 145 0.6× 86 0.4× 248 1.3× 29 1.2k

Countries citing papers authored by Danuta J. Herzyk

Since Specialization
Citations

This map shows the geographic impact of Danuta J. Herzyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danuta J. Herzyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danuta J. Herzyk more than expected).

Fields of papers citing papers by Danuta J. Herzyk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danuta J. Herzyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danuta J. Herzyk. The network helps show where Danuta J. Herzyk may publish in the future.

Co-authorship network of co-authors of Danuta J. Herzyk

This figure shows the co-authorship network connecting the top 25 collaborators of Danuta J. Herzyk. A scholar is included among the top collaborators of Danuta J. Herzyk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danuta J. Herzyk. Danuta J. Herzyk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pallardy, Marc, Rami Bechara, Jessica Whritenour, et al.. (2024). Drug hypersensitivity reactions: review of the state of the science for prediction and diagnosis. Toxicological Sciences. 200(1). 11–30. 7 indexed citations
2.
Ackley, David H., Todd Bourcier, Andrew L. Goodwin, et al.. (2022). FDA and industry collaboration: Identifying opportunities to further reduce reliance on nonhuman primates for nonclinical safety evaluations. Regulatory Toxicology and Pharmacology. 138. 105327–105327. 22 indexed citations
3.
Santostefano, Michael J., Danuta J. Herzyk, Diana Montgomery, & Jayanthi Wolf. (2019). Nonclinical safety of tildrakizumab, a humanized anti–IL-23p19 monoclonal antibody, in nonhuman primates. Regulatory Toxicology and Pharmacology. 108. 104476–104476. 6 indexed citations
4.
Herzyk, Danuta J. & Helen G. Haggerty. (2018). Cancer Immunotherapy: Factors Important for the Evaluation of Safety in Nonclinical Studies. The AAPS Journal. 20(2). 28–28. 9 indexed citations
5.
Piccotti, Joseph R., Hervé Lebrec, Ellen W. Evans, et al.. (2009). Summary of a workshop on nonclinical and clinical immunotoxicity assessment of immunomodulatory drugs. Journal of Immunotoxicology. 6(1). 1–10. 6 indexed citations
6.
Ponce, Rafael, Leslie W. Abad, Lakshmi Amaravadi, et al.. (2009). Immunogenicity of biologically-derived therapeutics: Assessment and interpretation of nonclinical safety studies. Regulatory Toxicology and Pharmacology. 54(2). 164–182. 179 indexed citations
7.
Gore, Elizabeth R., et al.. (2004). Primary antibody response to keyhole limpet hemocyanin in rat as a model for immunotoxicity evaluation. Toxicology. 197(1). 23–35. 43 indexed citations
8.
Herzyk, Danuta J.. (2004). Adequate immunotoxicity testing in drug development. Toxicology Letters. 149(1-3). 115–122. 9 indexed citations
9.
Soos, Jeanne M., et al.. (2003). Identification of natural antibodies to interleukin-18 in the sera of normal humans and three nonhuman primate species. Clinical Immunology. 109(2). 188–196. 9 indexed citations
10.
Herzyk, Danuta J., Jeanne M. Soos, Curtis C. Maier, et al.. (2002). IMMUNOPHARMACOLOGY OF RECOMBINANT HUMAN INTERLEUKIN-18 IN NON-HUMAN PRIMATES. Cytokine. 20(1). 38–48. 11 indexed citations
11.
Hart, Timothy K., Richard M. Cook, Parnian Zia‐Amirhosseini, et al.. (2001). Preclinical efficacy and safety of mepolizumab (SB-240563), a humanized monoclonal antibody to IL-5, in cynomolgus monkeys. Journal of Allergy and Clinical Immunology. 108(2). 250–257. 182 indexed citations
12.
Davis, Charles B., et al.. (2000). Comparative Pharmacodynamics of Keliximab and Clenoliximab in Transgenic Mice Bearing Human CD4. Journal of Pharmacology and Experimental Therapeutics. 293(1). 33–41. 23 indexed citations
13.
Bugelski, Peter J., Johanne Kaplan, Daniel E. Everitt, et al.. (1996). Relationships between antibodies against human soluble complement receptor 1 (hsCR1) from various species. Journal of Clinical Immunology. 16(2). 97–106. 2 indexed citations
14.
Everitt, Daniel E., Charles B. Davis, Katherine A. Thompson, et al.. (1996). The Pharmacokinetics, Antigenicity, and Fusion-Inhibition Activity of RSHZ19, a Humanized Monoclonal Antibody to Respiratory Syncytial Virus, in Healthy Volunteers. The Journal of Infectious Diseases. 174(3). 463–469. 41 indexed citations
15.
Kaplan, Johanne, et al.. (1995). Effect of TNFα production inhibitors BRL 61063 and pentoxifylline on the response of rats to poly I:C. Toxicology. 95(1-3). 187–196. 9 indexed citations
16.
Davis, Charles B., Deborah Kwok, T K Hart, et al.. (1995). Preclinical pharmacokinetic evaluation of the respiratory syncytial virus-specific reshaped human monoclonal antibody RSHZ19.. Drug Metabolism and Disposition. 23(10). 1028–1036. 26 indexed citations
17.
Herzyk, Danuta J., et al.. (1993). ELISA Detection of IL-Iβ in Human Sera Needs Independent Confirmation: False Positives in Hospitalized Patients. American Review of Respiratory Disease. 147(1). 139–142. 10 indexed citations
18.
Wewers, Mark D., et al.. (1993). Tumor Necrosis Factor Increases the Elastolytic Potential of Adherent Neutrophils: A Role for Hypochlorous Acid. American Journal of Respiratory Cell and Molecular Biology. 9(4). 386–392. 9 indexed citations
19.
Herzyk, Danuta J., Ann E. Berger, James N. Allen, & Mark D. Wewers. (1992). Sandwich ELISA formats designed to detect 17 kDa IL-1β significantly underestimate 35 kDa IL-1β. Journal of Immunological Methods. 148(1-2). 243–254. 52 indexed citations
20.
Wewers, Mark D., et al.. (1988). Alveolar fluid neutrophil elastase activity in the adult respiratory distress syndrome is complexed to alpha-2-macroglobulin.. Journal of Clinical Investigation. 82(4). 1260–1267. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ullrich Schwertschlag Breakdown of academic impact, for papers by S Douches Breakdown of academic impact, for papers by J.L. Touraine Breakdown of academic impact, for papers by Takeshi Otsuka Breakdown of academic impact, for papers by Zaher A. Radi Breakdown of academic impact, for papers by Sharad D. Deodhar Breakdown of academic impact, for papers by Jürgen E. Scherberich Breakdown of academic impact, for papers by Eric R. Hurd Breakdown of academic impact, for papers by Jeng‐Hsien Yen Breakdown of academic impact, for papers by R. van Furth
Rankless by CCL
2026